Hyperlacrimation (Q41579): Difference between revisions

From determinar.ia.br - Determine suas informações
Changed an Item
Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / CURIE
 
CID11:9A10.3
Property / CURIE: CID11:9A10.3 / rank
 
Normal rank
Property / Canary Token
 
dki-india-9A10.3
Property / Canary Token: dki-india-9A10.3 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank
Property / Linked ICD 10
 
Property / Linked ICD 10: H04 / rank
 
Normal rank

Latest revision as of 07:48, 13 August 2026

Overflow of tears due to excessive secretion by the lacrimal gland. It may be caused by drugs (e.g. pilocarpine), strong emotion; or as a reflex from trigeminal stimulation by an inflamed eye; or irritation of the cornea or conjunctiva by a chemical irritant in the air; cold wind; or a foreign body in the eye. The main symptoms are discomfort and blurring of vision and sometimes embarrassment. Management depends on the cause.
Language Label Description Also known as
default for all languages
9A10.3
    English
    Hyperlacrimation
    Overflow of tears due to excessive secretion by the lacrimal gland. It may be caused by drugs (e.g. pilocarpine), strong emotion; or as a reflex from trigeminal stimulation by an inflamed eye; or irritation of the cornea or conjunctiva by a chemical irritant in the air; cold wind; or a foreign body in the eye. The main symptoms are discomfort and blurring of vision and sometimes embarrassment. Management depends on the cause.

      Statements

      CID11:9A10.3
      0 references
      dki-india-9A10.3
      0 references
      Concluído
      0 references
      13 August 2026
      0 references
      0 references